| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
1.042 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
GNAI2 |
Galphai2 protein |
1.042 |
Evidence |
|
| KCNJ3 |
KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 |
KCNJ12 |
KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 |
1.042 |
Evidence |
|
| TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
RYR1 |
|
1.042 |
Evidence |
|
| CFB |
CFB, BF, BFD: Complement factor B precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
1.042 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
1.042 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
1.042 |
Evidence |
|
| TNFSF12 |
TNFSF12, APO3L, UNQ181/PRO207, DR3LG: Tumor necrosis factor ligand superfamily m |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.042 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.042 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
1.042 |
Evidence |
|
| KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.042 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
1.042 |
Evidence |
|
| CMA1 |
CMA1, CYH, CYM: Chymase precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
1.042 |
Evidence |
|
| F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.042 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
1.042 |
Evidence |
O
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.042 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.042 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
1.042 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
1.042 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
1.042 |
Evidence |
|
| CA9 |
CA9, G250, MN: Carbonic anhydrase 9 precursor |
SLC4A7 |
SLC4A7: Uncharacterized protein SLC4A7 |
1.042 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
1.042 |
Evidence |
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
1.042 |
Evidence |
|
| SERPINB4 |
SERPINB3, SCCA, SCCA1: Serpin B3 |
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
1.042 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.042 |
Evidence |
|
- 
-